Normalized claim
Annual savings: 10,000,000 USD decrease
saving tens of millions of dollars annually
Pfizer at AWS re:Invent 2023 | VOX generative AI on AWS
Use case typeGenerative AI transformationUpdated 3 days ago
Pfizer used AWS to centralize data, build a Scientific Data Cloud, and create VOX, a generative AI solution that uses large language models to accelerate research and predict product yield. The Scientific Data Cloud aggregates data from hundreds of laboratory instruments to make it simpler and faster for scientists to search the data.
- Organization
- Pfizer
- Industry
- Pharma
- Location
- United States
- Published
- July 2026
Reported outcomes
People treated with medicines and vaccines: More than 1,300,000,000 people
Other quantified impact
Annual savings: 10,000,000 USD
Strategic outcomes
Cost efficiencyGenerated major annual savingsOther strategic outcomeAccelerated research workflowsScale & capacitySupported global treatment scale and faster innovation
Why do we believe this?Outcome claims, sources, and evidence checks
Normalized claim
People treated with medicines and vaccines: 1,300,000,000 people increase
to treat more than 1.3 billion people with medicines and vaccines in 2022
Why do we believe this deployment?Customer identity, provider attribution, maturity, and source checks
- Customer
- Pfizer
- Provider
- AWS
- Maturity
- Unknown
- Linked source
- AWS re:Invent customer keynote
No explicit deployment-stage evidence found.
Customer identity supportedSource describes one deploymentMaturity evidence evaluated
Primary read
Use case focus
Showing 3 of 4
- 1Generative AI transformation
- 2Data platform modernization
- 3Search modernization
- Accelerate research and improve product yield while supporting rapid scaling of AI and data platforms.
- Centralize scientific and laboratory data so scientists can search it faster.
- Pfizer and AWS created the Scientific Data Cloud to aggregate data from hundreds of laboratory instruments.
- Pfizer built VOX on AWS using Amazon SageMaker and Amazon Bedrock to accelerate research, predict product yield, and support delivery of more medicines.
- AWS also provided on-demand compute capacity during the COVID-19 response.
Pfizer said the work helped it save tens of millions of dollars annually, enabled scale to treat more than 1.3 billion people with medicines and vaccines in 2022, and supported faster innovation and COVID-19 response.
Sources & evidence1
Evidence: Low35/100Evidence strength
- Customer explicitly identified
- Quantified outcome available
- Technical implementation details available
Type: Video Or WebinarPublished: Jul 30, 2026Publisher: AWSEvidence: VendorConfidence: Medium
AI-generated summary. Verify important details with the linked sources before relying on this case.
Explore related AI use cases
Customer evidence
Provider evidence
Browse the catalog
Was this useful?
Community
Comments
No published comments yet.